| Dr Ngii N Tazeh, MD, PHD | |
|
515 22nd Ave, Monroe, WI 53566-1569 | |
| (608) 324-2222 | |
| Not Available |
| Full Name | Dr Ngii N Tazeh |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 12 Years |
| Location | 515 22nd Ave, Monroe, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508123787 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 61264 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Monroe Clinic | Monroe, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Monroe Clinic Inc | 3072425495 | 152 |
| The Monroe Clinic Inc | 3072425495 | 152 |
News Archive
Former Democratic congressman Bart Stupak is relishing the good life. After nine terms in the House of Representatives, the once obscure, pro-life, conservative legislator who became the flash point in last year's historic health care debate gave up his seat to become a gilded Washington operative -; a partner in the Government and Legislative Affairs Group of Venable LLP. … Even before he negotiated a last-minute deal with President Obama to ban federal funding for abortion and provided the defining vote, he called his life "a living hell." "I was the face of health care. Whatever you thought about it, I was it," he says calmly. "I'm surprised I never got shot."
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Among children born full term, those conceived with the help of fertility drugs are slightly shorter than naturally conceived children but overall are physically healthy, a new study finds. Results of the study will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
Chronic hepatitis B infection usually will lead to liver inflammation and can progress to cirrhosis and liver cancer. The reported infection rate is 35 times higher than the rate in the general U.S. population.
Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).
› Verified 4 days ago
| Entity Name | The Monroe Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386720548 PECOS PAC ID: 3072425495 Enrollment ID: O20031104000392 |
News Archive
Former Democratic congressman Bart Stupak is relishing the good life. After nine terms in the House of Representatives, the once obscure, pro-life, conservative legislator who became the flash point in last year's historic health care debate gave up his seat to become a gilded Washington operative -; a partner in the Government and Legislative Affairs Group of Venable LLP. … Even before he negotiated a last-minute deal with President Obama to ban federal funding for abortion and provided the defining vote, he called his life "a living hell." "I was the face of health care. Whatever you thought about it, I was it," he says calmly. "I'm surprised I never got shot."
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Among children born full term, those conceived with the help of fertility drugs are slightly shorter than naturally conceived children but overall are physically healthy, a new study finds. Results of the study will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
Chronic hepatitis B infection usually will lead to liver inflammation and can progress to cirrhosis and liver cancer. The reported infection rate is 35 times higher than the rate in the general U.S. population.
Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ngii N Tazeh, MD, PHD 515 22nd Ave, Monroe, WI 53566-1569 Ph: (608) 628-3965 | Dr Ngii N Tazeh, MD, PHD 515 22nd Ave, Monroe, WI 53566-1569 Ph: (608) 324-2222 |
News Archive
Former Democratic congressman Bart Stupak is relishing the good life. After nine terms in the House of Representatives, the once obscure, pro-life, conservative legislator who became the flash point in last year's historic health care debate gave up his seat to become a gilded Washington operative -; a partner in the Government and Legislative Affairs Group of Venable LLP. … Even before he negotiated a last-minute deal with President Obama to ban federal funding for abortion and provided the defining vote, he called his life "a living hell." "I was the face of health care. Whatever you thought about it, I was it," he says calmly. "I'm surprised I never got shot."
The Pharmabiotic Research Institute (PRI), Europe's only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled "Live biotherapeutic products: the importance of a defined regulatory framework".
Among children born full term, those conceived with the help of fertility drugs are slightly shorter than naturally conceived children but overall are physically healthy, a new study finds. Results of the study will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
Chronic hepatitis B infection usually will lead to liver inflammation and can progress to cirrhosis and liver cancer. The reported infection rate is 35 times higher than the rate in the general U.S. population.
Relypsa, Inc. today announced the presentation of positive results from a Phase 2 clinical trial of the company's lead compound, RLY5016, a non-absorbed oral potassium binder being developed as a treatment for hyperkalemia (elevated serum potassium levels).
› Verified 4 days ago